Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Exagen Inc. (XGN)
USD4.28
+0.19 (+4.65%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
1261 Liberty Way 92081
Vista, CA, US
Vista, CA, US
CEO
John Aballi
Website
exagen.com
IPO
2019-09-19
CIK 1274737 ISIN US30068X1037
Description
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of autoimmune and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its flagship product, AVISE CTD, aids in distinguishing between various connective tissue diseases (CTDs) and other conditions with overlapping symptoms in symptomatic patients. The company's product portfolio includes AVISE Lupus, which assesses complement system activation by measuring B-cell C4d and erythrocyte-bound C4d in blood. AVISE APS offers a comprehensive panel of autoantibody tests for the diagnosis and management of Antiphospholipid Syndrome (APS). For SLE patients, AVISE SLE Prognostic provides an autoantibody panel to evaluate the potential for kidney, brain, and cardiovascular complications. Additionally, AVISE Vasculitis AAV utilizes a testing panel of individual analytes to assist physicians in the assessment and monitoring of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, while AVISE Anti-CarP helps identify RA patients prone to severe disease, and AVISE PC4d measures platelet-bound C4d. Further offerings include AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, designed to monitor hydroxychloroquine levels. Exagen also holds a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to advance the development of novel patented biomarkers. Incorporated in 2002, the company was formerly known as Exagen Diagnostics, Inc. before rebranding to Exagen Inc. in January 2019. Its headquarters are located in Vista, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.28
+0.19 (+4.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
392.9K
Beta
2.02
Float Shares
16.20M
Free Float %
67.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.78% | +19.68% | +22.44% | +14.51% | -61.31% | -38.98% | -35.70% | +26.62% | -71.13% | -80.03% | -80.03% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
4.28
Low
8.00
+86.9%
Consensus
8.67
+102.6%
Median
8.00
+86.9%
High
10.00
+133.6%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
8.00
+86.9%
|
| Last Quarter | 4 |
9.25
+116.1%
|
| Last Year | 8 |
11.13
+160.0%
|
| All Time | 11 |
9.64
+125.2%
|
Quality scores
Altman Z-Score
-6.23
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+19.7% ★ Q1'26: +11.7% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%-12.1% Q1'26: +15.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-28.5% Q1'26: -61.5% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-21.1% Q1'26: -19.7% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%— Q1'26: +613.5% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+18.4% Q1'26: +28.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-0.45× Q1'26: -0.36× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
40.39M
est: 40.55M (-0.4%)
|
41.98M
est: 39.98M (+5.0%)
|
48.30M
est: 47.30M (+2.1%)
|
45.56M
est: 41.59M (+9.6%)
|
52.55M
est: 56.66M (-7.3%)
|
55.64M
est: 55.49M (+0.3%)
|
66.58M
est: 66.48M (+0.1%)
|
71.32M
70.69M – 71.69M
+7.3% YoY
|
79.39M
78.46M – 81.16M
+11.3% YoY
|
89.95M
88.88M – 91.03M
+13.3% YoY
|
100.20M
98.97M – 101.85M
+11.4% YoY
|
101.50M
100.26M – 103.17M
+1.3% YoY
|
| EBITDA |
-7.93M
est: -18.87M (+58.0%)
|
-13.66M
est: -18.60M (+26.6%)
|
-23.10M
est: -22.01M (-5.0%)
|
-43.66M
est: -19.35M (-125.6%)
|
-19.15M
est: -24.71M (+22.5%)
|
-11.15M
est: -24.20M (+54.0%)
|
-11.95M
est: -29.00M (+58.8%)
|
-31.11M
-31.27M – -30.83M
-7.3% YoY
|
-34.63M
-35.40M – -34.22M
-11.3% YoY
|
-39.24M
-39.70M – -38.77M
-13.3% YoY
|
-43.71M
-44.43M – -43.17M
-11.4% YoY
|
-44.27M
-45.00M – -43.73M
-1.3% YoY
|
| EBIT |
-8.52M
est: -20.00M (+57.4%)
|
-14.20M
est: -19.71M (+28.0%)
|
-24.05M
est: -23.32M (-3.1%)
|
-45.22M
est: -20.51M (-120.5%)
|
-21.32M
est: -26.50M (+19.6%)
|
-12.87M
est: -25.96M (+50.4%)
|
-14.07M
est: -31.10M (+54.8%)
|
-33.36M
-33.54M – -33.07M
-7.3% YoY
|
-37.13M
-37.96M – -36.70M
-11.3% YoY
|
-42.08M
-42.58M – -41.57M
-13.3% YoY
|
-46.87M
-47.64M – -46.30M
-11.4% YoY
|
-47.48M
-48.26M – -46.90M
-1.3% YoY
|
| Net Income |
-12.04M
est: -99.66M (+87.9%)
|
-16.69M
est: -26.29M (+36.5%)
|
-26.85M
est: -31.93M (+15.9%)
|
-47.39M
est: -49.40M (+4.1%)
|
-23.69M
est: -20.89M (-13.4%)
|
-15.12M
est: -19.05M (+20.7%)
|
-19.95M
est: -18.97M (-5.2%)
|
-15.38M
-15.98M – -14.78M
+18.9% YoY
|
-10.80M
-11.14M – -10.45M
+29.8% YoY
|
-6.92M
-7.05M – -6.79M
+35.9% YoY
|
-2.80M
-2.86M – -2.76M
+59.5% YoY
|
-3.66M
-3.74M – -3.61M
-30.8% YoY
|
| SGA |
28.70M
est: 37.24M (-22.9%)
|
37.03M
est: 36.72M (+0.9%)
|
44.54M
est: 43.44M (+2.5%)
|
52.02M
est: 38.20M (+36.2%)
|
47.43M
est: 49.98M (-5.1%)
|
41.37M
est: 48.95M (-15.5%)
|
46.62M
est: 58.64M (-20.5%)
|
62.91M
62.35M – 63.24M
+7.3% YoY
|
70.02M
69.20M – 71.58M
+11.3% YoY
|
79.34M
78.39M – 80.29M
+13.3% YoY
|
88.38M
87.30M – 89.83M
+11.4% YoY
|
89.53M
88.43M – 91.00M
+1.3% YoY
|
| EPS |
-0.96
est: -5.48 (+82.5%)
|
-1.32
est: -1.44 (+8.6%)
|
-1.68
est: -1.75 (+4.2%)
|
-2.77
est: -2.71 (-2.4%)
|
-1.34
est: -0.97 (-38.6%)
|
-0.83
est: -0.89 (+6.6%)
|
-0.93
est: -0.88 (-5.7%)
|
-0.71
-0.74 – -0.69
+18.9% YoY
|
-0.51
-0.52 – -0.48
+29.1% YoY
|
-0.32
-0.33 – -0.31
+36.8% YoY
|
-0.13
-0.13 – -0.13
+59.4% YoY
|
-0.17
-0.17 – -0.17
-30.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | Canaccord Genuity | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-12.60M
OE per share TTM
-0.55
Owner's Yield
-13.27%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
13.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
14
Total invested
5.10M
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sun Mountain Capital Partners, L.L.C. | 2.43M | 19.26% | 2.43M | — | 2.43M | — | PN | — | 2020-09-18 | ↗ |
| 2 | NMSIC Co-Investment Fund, L.P. | 2.31M | 14.28% | 2.31M | — | 2.31M | — | PN | Delaware | 2022-02-10 | ↗ |
| 3 | James L.L. Tullis | 2.13M | 17.00% | 54.5K | 2.08M | 54.5K | — | IN | United States | 2020-02-14 | ↗ |
| 4 | Anthony Tamer | 1.70M | 13.40% | — | 1.70M | — | 1.70M | IN | — | 2021-02-24 | ↗ |
| 5 | Bio-Exagen, | 1.70M | 13.40% | — | 1.70M | — | 1.70M | PN | — | 2021-02-24 | ↗ |
| 6 | H.I.G.-GPII, Inc. | 1.70M | 13.40% | — | 1.70M | — | 1.70M | CO | — | 2021-02-24 | ↗ |
| 7 | Sami Mnaymneh | 1.70M | 13.40% | — | 1.70M | — | 1.70M | PN | — | 2021-02-24 | ↗ |
| 8 | RTW Investments, LP | 1.25M | 9.89% | — | 1.25M | — | 1.25M | IA, PN, OO | Delaware | 2021-02-12 | ↗ |
| 9 | Tullis Dickerson Partners III, L.L.C. | 1.22M | 9.70% | — | 1.22M | — | — | PN | Delaware | 2020-02-14 | ↗ |
| 10 | Tullis-Dickerson Capital Focus III, L.P. | 1.11M | 8.70% | 44.9K | — | — | — | PN | Delaware | 2021-02-16 | ↗ |
| 11 | Wasatch Advisors, Inc. 87-0319391 | 1.04M | 8.30% | 1.04M | — | 1.04M | — | IA | — | 2021-02-11 | ↗ |
| 12 | BANK OF MONTREAL | 1.02M | 6.30% | 1.02M | — | 1.02M | — | HC | Canada | 2022-02-15 | ↗ |
| 13 | BMO CAPITAL MARKETS CORP. | 1.02M | 6.30% | 1.02M | — | 1.02M | — | HC | Canada | 2022-02-15 | ↗ |
| 14 | BMO FINANCIAL CORP. | 1.02M | 6.30% | 1.02M | — | 1.02M | — | HC | Canada | 2022-02-15 | ↗ |
| 15 | Jon M. Plexico | 858.6K | 11.00% | 858.6K | — | 858.6K | — | HC, IN | California | 2022-02-14 | ↗ |
| 16 | Stonepine Capital Management, LLC | 858.6K | 11.00% | 858.6K | — | 858.6K | — | IA, OO | California | 2022-02-14 | ↗ |
| 17 | Stonepine Capital, L.P. | 858.6K | 11.00% | 858.6K | — | 858.6K | — | PN | Delaware | 2022-02-14 | ↗ |
| 18 | Timothy P. Lynch | 858.6K | 11.00% | 858.6K | — | 858.6K | — | HC, IN | U.S.A. | 2022-02-14 | ↗ |
| 19 | Laurence W. Lytton | 833.3K | 11.00% | 833.3K | — | 833.3K | — | IN | USA | 2022-11-23 | ↗ |
| 20 | Roderick Wong | 821.4K | 5.10% | — | 821.4K | — | — | HC, IN | Delaware | 2022-02-14 | ↗ |
| 21 | Tullis Growth Fund, L.P. | 751.4K | 6.00% | — | 751.4K | — | — | PN | Delaware | 2020-02-14 | ↗ |
| 22 | Tullis-Growth Partners, L.L.C. | 751.4K | 6.00% | — | 751.4K | — | — | PN | Delaware | 2020-02-14 | ↗ |
| 23 | Tullis Growth Fund II, L.P. | 105.5K | 0.80% | — | 105.5K | — | — | PN | — | 2020-02-14 | ↗ |
| 24 | Tullis-Growth Partners II, L.L.C. | 105.5K | 0.80% | — | 105.5K | — | — | PN | Delaware | 2020-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
14
-68 vs prev Q
New positions
4
Closed positions
70
Increased
10
Reduced
4
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 250.0K +250.0K (+100.0%) | 1.52B +1.5B (+100.0%) | 1.09% +1.094 pp | 1.30% +1.297 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 2 | BALYASNY ASSET MANAGEMENT L.P. | 919.2K +195.8K (+27.1%) | 5.59M -2.4M (-29.7%) | 4.02% +0.590 pp | 0.01% -0.003 pp | USD6.81 -10.7% | 3 qtrs — |
| 3 | RTW INVESTMENTS, LP | 790.5K -906.4K (-53.4%) | 4.81M -13.8M (-74.2%) | 3.46% -4.590 pp | 0.05% -0.182 pp | USD10.80 -43.7% | 26 qtrs — |
| 4 | VANGUARD GROUP INC | 790.0K +56.2K (+7.7%) | 4.80M -3.3M (-40.4%) | 3.46% -0.025 pp | 0.00% 0.000 pp | USD14.74 -58.8% | 26 qtrs — |
| 5 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 597.9K +78.5K (+15.1%) | 3.64M -2.1M (-36.3%) | 2.62% +0.152 pp | 0.03% -0.013 pp | USD13.44 -54.8% | 20 qtrs — |
| 6 | KENNEDY CAPITAL MANAGEMENT LLC | 480.0K -71.8K (-13.0%) | 2.92M -3.1M (-51.9%) | 2.10% -0.517 pp | 0.06% -0.072 pp | USD6.60 -7.9% | 7 qtrs — |
| 7 | WEXFORD CAPITAL LP | 466.8K +21.9K (+4.9%) | 2.84M -2.1M (-42.0%) | 2.04% -0.068 pp | 0.55% -0.155 pp | USD7.18 -15.3% | 3 qtrs — |
| 8 | ACADIAN ASSET MANAGEMENT LLC | 414.4K +300.6K (+264.1%) | 2.52M +1.3M (+101.5%) | 1.81% +1.273 pp | 0.00% +0.002 pp | USD7.25 -16.1% | 4 qtrs — |
| 9 | TWO SIGMA INVESTMENTS, LP | 368.3K +130.3K (+54.7%) | 2.24M -376.4K (-14.4%) | 1.61% +0.482 pp | 0.00% -0.001 pp | USD8.57 -29.1% | 3 qtrs — |
| 10 | MINK BROOK ASSET MANAGEMENT LLC | 353.7K +313.7K (+784.3%) | 2.15M +1.7M (+389.2%) | 1.55% +1.358 pp | 1.36% +1.063 pp | USD6.18 -1.6% | 3 qtrs — |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 303.3K +101.2K (+50.0%) | 1.84M -377.5K (-17.0%) | 1.33% +0.368 pp | 0.00% +0.000 pp | USD9.35 -35.0% | 2 qtrs — |
| 12 | FOURWORLD CAPITAL MANAGEMENT LLC | 273.0K +46.0K (+20.3%) | 1.66M -834.9K (-33.5%) | 1.19% +0.118 pp | 1.35% -2.593 pp | USD7.10 -14.4% | 3 qtrs — |
| 13 | MARSHALL WACE, LLP | 243.4K +218.8K (+888.2%) | 1.48M +1.2M (+446.7%) | 1.06% +0.948 pp | 0.00% +0.001 pp | USD6.58 -7.6% | 5 qtrs — |
| 14 | MILLENNIUM MANAGEMENT LLC | 224.6K -22.6K (-9.1%) | 1.37M -1.4M (-49.7%) | 0.98% -0.190 pp | 0.00% -0.001 pp | USD10.99 -44.7% | 2 qtrs — |
| 15 | POINT72 ASSET MANAGEMENT, L.P. | 205.2K +205.2K (+100.0%) | 1.25M +1.2M (+100.0%) | 0.90% +0.898 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 3 qtrs — |
| 16 | JANE STREET GROUP, LLC | 194.0K +91.7K (+89.7%) | 1.18M +55.4K (+4.9%) | 0.85% +0.364 pp | 0.00% +0.000 pp | USD8.67 -29.9% | 2 qtrs — |
| 17 | AMERIPRISE FINANCIAL INC | 192.4K +64.1K (+49.9%) | 1.17M -240.6K (-17.1%) | 0.84% +0.233 pp | 0.00% 0.000 pp | USD7.38 -17.6% | 3 qtrs — |
| 18 | CITADEL ADVISORS LLC | 188.5K +72.2K (+62.1%) | 1.15M -131.5K (-10.3%) | 0.82% +0.273 pp | 0.00% +0.000 pp | USD9.11 -33.3% | 9 qtrs — |
| 19 | RUSSELL INVESTMENTS GROUP, LTD. | 187.9K -41.2K (-18.0%) | 1.14M -1.4M (-54.6%) | 0.82% -0.265 pp | 0.00% -0.002 pp | USD7.13 -14.7% | 3 qtrs — |
| 20 | MANATUCK HILL PARTNERS, LLC | 175.0K +— (+0.0%) | 1.06M -859.3K (-44.7%) | 0.77% -0.065 pp | 0.37% -0.264 pp | USD6.98 -12.9% | 3 qtrs — |
| 21 | QUBE RESEARCH & TECHNOLOGIES LTD | 174.2K +97.6K (+127.3%) | 1.06M +217.0K (+25.8%) | 0.76% +0.399 pp | 0.00% +0.000 pp | USD8.24 -26.2% | 2 qtrs — |
| 22 | GEODE CAPITAL MANAGEMENT, LLC | 172.7K +9.4K (+5.8%) | 1.05M -744.2K (-41.5%) | 0.76% -0.019 pp | 0.00% +0.000 pp | USD11.53 -47.3% | 25 qtrs — |
| 23 | MASSAR CAPITAL MANAGEMENT, LP | 170.0K +— (+0.0%) | 1.03M -834.7K (-44.7%) | 0.74% -0.063 pp | 0.11% -0.135 pp | USD6.56 -7.3% | 4 qtrs — |
| 24 | TWO SIGMA ADVISERS, LP | 161.0K +76.9K (+91.4%) | 978.9K +54.6K (+5.9%) | 0.70% +0.305 pp | 0.00% +0.000 pp | USD8.64 -29.6% | 2 qtrs — |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 138.0K +138.0K (+100.0%) | 839.0K +839.0K (+100.0%) | 0.60% +0.604 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 9 qtrs — |
| 26 | BNP PARIBAS ARBITRAGE, SNC | 133.2K +86.4K (+184.5%) | 810.1K +295.4K (+57.4%) | 0.58% +0.361 pp | 0.00% +0.000 pp | USD7.80 -22.1% | 5 qtrs — |
| 27 | BLACKROCK, INC. | 129.6K +47.2K (+57.4%) | 788.0K -117.2K (-12.9%) | 0.57% +0.176 pp | 0.00% +0.000 pp | USD5.68 +7.0% | 6 qtrs — |
| 28 | SEI INVESTMENTS CO | 118.0K +118.0K (+100.0%) | 717.5K +717.5K (+100.0%) | 0.52% +0.516 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 29 | UBS GROUP AG | 113.0K +23.0K (+25.5%) | 687.0K -302.2K (-30.6%) | 0.49% +0.067 pp | 0.00% +0.000 pp | USD7.57 -19.7% | 25 qtrs — |
| 30 | 683 CAPITAL MANAGEMENT, LLC | 107.6K +107.6K (+100.0%) | 654.0K +654.0K (+100.0%) | 0.47% +0.471 pp | 0.03% +0.029 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 31 | MORGAN STANLEY | 97.4K +54.4K (+126.2%) | 592.4K +119.0K (+25.1%) | 0.43% +0.222 pp | 0.00% +0.000 pp | USD9.59 -36.6% | 26 qtrs — |
| 32 | XTX TOPCO LTD | 97.0K +69.2K (+248.5%) | 589.7K +283.8K (+92.8%) | 0.42% +0.292 pp | 0.02% 0.000 pp | USD6.70 -9.3% | 3 qtrs — |
| 33 | JUMP FINANCIAL, LLC | 95.8K +95.8K (+100.0%) | 582.7K +582.7K (+100.0%) | 0.42% +0.419 pp | 0.01% +0.007 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 34 | OMERS ADMINISTRATION CORP | 90.0K +90.0K (+100.0%) | 547.2K +547.2K (+100.0%) | 0.39% +0.394 pp | 0.00% +0.004 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 35 | SQUAREPOINT OPS LLC | 88.0K +88.0K (+100.0%) | 535.2K +535.2K (+100.0%) | 0.39% +0.385 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 36 | GOLDMAN SACHS GROUP INC | 81.6K +19.8K (+32.0%) | 496.3K -183.1K (-27.0%) | 0.36% +0.064 pp | 0.00% +0.000 pp | USD8.69 -30.0% | 3 qtrs — |
| 37 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77.2K +49.4K (+177.7%) | 469.4K +163.9K (+53.6%) | 0.34% +0.206 pp | 0.01% +0.003 pp | USD7.39 -17.7% | 22 qtrs — |
| 38 | STATE STREET CORP | 71.3K +4.6K (+6.9%) | 433.2K -299.3K (-40.9%) | 0.31% -0.004 pp | 0.00% +0.000 pp | USD10.80 -43.7% | 25 qtrs — |
| 39 | HRT FINANCIAL LP | 69.7K +69.7K (+100.0%) | 423.0K +423.0K (+100.0%) | 0.31% +0.305 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 40 | ENGINEERS GATE MANAGER LP | 63.0K +21.8K (+52.9%) | 382.8K -69.8K (-15.4%) | 0.28% +0.080 pp | 0.00% -0.001 pp | USD9.29 -34.6% | 2 qtrs — |
| 41 | HUNTLEIGH ADVISORS, INC. | 57.2K -36.2K (-38.7%) | 347.7K -678.2K (-66.1%) | 0.25% -0.193 pp | 0.06% -0.116 pp | USD4.59 +32.5% | 5 qtrs — |
| 42 | — | 57.0K +57.0K (+100.0%) | 346.6K +346.6K (+100.0%) | 0.25% +0.249 pp | 0.43% +0.430 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 43 | CALAMOS ADVISORS LLC | 56.3K -21.8K (-27.9%) | 342.3K -515.9K (-60.1%) | 0.25% -0.124 pp | 0.00% -0.002 pp | USD7.12 -14.6% | 3 qtrs — |
| 44 | TREXQUANT INVESTMENT LP | 55.6K +44.5K (+400.8%) | 338.1K +216.1K (+177.0%) | 0.24% +0.191 pp | 0.00% +0.002 pp | USD7.06 -13.9% | 2 qtrs — |
| 45 | CITIZENS FINANCIAL GROUP INC/RI | 54.6K -2.9K (-5.0%) | 332.1K -300.1K (-47.5%) | 0.24% -0.034 pp | 0.00% -0.004 pp | USD6.98 -12.9% | 3 qtrs — |
| 46 | PALUMBO WEALTH MANAGEMENT LLC | 43.3K +5.7K (+15.2%) | 263.5K -150.0K (-36.3%) | 0.19% +0.011 pp | 0.07% -0.067 pp | USD2.85 +113.3% | 8 qtrs — |
| 47 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 39.3K +29.0K (+282.4%) | 239.1K +126.1K (+111.5%) | 0.17% +0.123 pp | 0.00% +0.001 pp | USD7.36 -17.4% | 2 qtrs — |
| 48 | STATE OF WYOMING | 37.9K +37.9K (+100.0%) | 230.7K +230.7K (+100.0%) | 0.17% +0.166 pp | 0.03% +0.025 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 49 | NORTHERN TRUST CORP | 37.5K +6.6K (+21.4%) | 228.3K -111.5K (-32.8%) | 0.16% +0.018 pp | 0.00% +0.000 pp | USD12.64 -51.9% | 25 qtrs — |
| 50 | BANK OF NEW YORK MELLON CORP | 35.4K +23.9K (+207.3%) | 215.1K +88.6K (+70.0%) | 0.15% +0.100 pp | 0.00% +0.000 pp | USD7.68 -20.8% | 2 qtrs — |
| 51 | GSA CAPITAL PARTNERS LLP | 34.5K +34.5K (+100.0%) | 210.0K +210.0K (+100.0%) | 0.15% +0.151 pp | 0.02% +0.018 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 52 | SHAY CAPITAL LLC | 33.7K +33.7K (+100.0%) | 204.9K +204.9K (+100.0%) | 0.15% +0.147 pp | 0.02% +0.021 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 53 | MAN GROUP PLC | 32.6K +32.6K (+100.0%) | 198.2K +198.2K (+100.0%) | 0.14% +0.143 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 54 | D. E. SHAW & CO., INC. | 31.6K +31.6K (+100.0%) | 192.0K +192.0K (+100.0%) | 0.14% +0.138 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 55 | OCCUDO QUANTITATIVE STRATEGIES LP | 30.2K +9.3K (+44.8%) | 183.7K -45.6K (-19.9%) | 0.13% +0.033 pp | 0.01% -0.016 pp | USD6.84 -11.1% | 3 qtrs — |
| 56 | DIMENSIONAL FUND ADVISORS LP | 26.4K -1.0K (-3.8%) | 160.2K -140.7K (-46.8%) | 0.12% -0.015 pp | 0.00% +0.000 pp | USD8.66 -29.8% | 19 qtrs — |
| 57 | HUDSON BAY CAPITAL MANAGEMENT LP | 24.2K +24.2K (+100.0%) | 147.0K +147.0K (+100.0%) | 0.11% +0.106 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 58 | BARCLAYS PLC | 23.6K +18.5K (+358.7%) | 143.5K +127.6K (+802.6%) | 0.10% +0.079 pp | 0.00% +0.000 pp | USD6.50 -6.5% | 16 qtrs — |
| 59 | DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 21.3K +21.3K (+100.0%) | 129.0K +129.0K (+100.0%) | 0.09% +0.093 pp | 0.03% +0.029 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 60 | WALLEYE CAPITAL LLC | 20.8K -51.9K (-71.3%) | 126.7K -672.4K (-84.1%) | 0.09% -0.254 pp | 0.00% -0.003 pp | USD10.99 -44.7% | 2 qtrs — |
| 61 | TORONTO DOMINION BANK | 20.0K +— (+0.0%) | 121.8K -98.3K (-44.7%) | 0.09% -0.007 pp | 0.00% 0.000 pp | USD4.10 +48.3% | 5 qtrs — |
| 62 | PERKINS CAPITAL MANAGEMENT INC | 18.6K -1.5K (-7.5%) | 112.9K -107.7K (-48.8%) | 0.08% -0.014 pp | 0.09% -0.105 pp | USD6.66 -8.7% | 22 qtrs — |
| 63 | R SQUARED LTD | 18.2K +18.2K (+100.0%) | 110.6K +110.6K (+100.0%) | 0.08% +0.080 pp | 0.05% +0.052 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 64 | BANK OF AMERICA CORP /DE/ | 17.6K -38.0K (-68.3%) | 107.0K -503.5K (-82.5%) | 0.08% -0.187 pp | 0.00% +0.000 pp | USD10.82 -43.8% | 25 qtrs — |
| 65 | CI PRIVATE WEALTH, LLC | 14.6K +14.6K (+100.0%) | 88.5K +88.5K (+100.0%) | 0.06% +0.064 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 5 qtrs — |
| 66 | JAIN GLOBAL LLC | 13.5K +13.5K (+100.0%) | 82.2K +82.2K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 67 | PENBROOK MANAGEMENT LLC | 13.4K -6.5K (-32.5%) | 81.7K -137.2K (-62.7%) | 0.06% -0.036 pp | 0.06% -0.097 pp | USD13.08 -53.5% | 18 qtrs — |
| 68 | SCHONFELD STRATEGIC ADVISORS LLC | 13.4K +13.4K (+100.0%) | 81.6K +81.6K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 69 | PERSISTENT ASSET PARTNERS LTD | 13.2K +13.2K (+100.0%) | 80.4K +80.4K (+100.0%) | 0.06% +0.058 pp | 0.04% +0.036 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 70 | BLUECREST CAPITAL MANAGEMENT LTD | 10.0K +10.0K (+100.0%) | 60.8K +60.8K (+100.0%) | 0.04% +0.044 pp | 0.00% +0.002 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 71 | TRUVESTMENTS CAPITAL LLC | 6.2K +3.2K (+109.5%) | 37.5K +5.2K (+15.9%) | 0.03% +0.013 pp | 0.01% +0.001 pp | USD6.82 -10.9% | 3 qtrs — |
| 72 | CANADA PENSION PLAN INVESTMENT BOARD | 4.9K +4.9K (+100.0%) | 29.8K +29.8K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 73 | WELLS FARGO & COMPANY/MN | 4.2K -1.2K (-22.5%) | 25.4K -33.8K (-57.1%) | 0.02% -0.007 pp | 0.00% +0.000 pp | USD5.76 +5.6% | 25 qtrs — |
| 74 | JPMORGAN CHASE & CO | 3.9K -12.1K (-75.6%) | 23.7K -152.3K (-86.5%) | 0.02% -0.059 pp | 0.00% +0.000 pp | USD10.99 -44.7% | 25 qtrs — |
| 75 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.5K +3.5K (+100.0%) | 21.5K +21.5K (+100.0%) | 0.02% +0.015 pp | 0.00% +0.001 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 76 | LARSON FINANCIAL GROUP LLC | 1.8K -7.7K (-80.6%) | 11.2K -93.3K (-89.3%) | 0.01% -0.037 pp | 0.00% -0.003 pp | USD10.99 -44.7% | 2 qtrs — |
| 77 | ROYAL BANK OF CANADA | 1.5K -3.1K (-68.1%) | 9.0K -41.0K (-82.0%) | 0.01% -0.015 pp | 0.00% +0.000 pp | USD6.61 -8.0% | 5 qtrs — |
| 78 | CWM, LLC | 1.4K +— (+0.0%) | 8.0K -7.0K (-46.7%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD10.99 -44.7% | 2 qtrs — |
| 79 | ADVISOR GROUP HOLDINGS, INC. | 1.0K +— (+0.0%) | 6.1K -3.8K (-38.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.09 +96.8% | 6 qtrs — |
| 80 | JONES FINANCIAL COMPANIES LLLP | 200.00 +200.0 (+100.0%) | 1.2K +1.2K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD6.08 +0.0% | 1 qtrs NEW |
| 81 | INVESCO LTD. | — -675.2K (-100.0%) | — -7.4M (-100.0%) | 0.00% -3.202 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 82 | CITIGROUP INC | — -2.0K (-100.0%) | — -22.5K (-100.0%) | 0.00% -0.010 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 83 | FEDERATED HERMES, INC. | — -1.2K (-100.0%) | — -13.7K (-100.0%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 84 | NKCFO LLC | — -40.0K (-100.0%) | — -440.0K (-100.0%) | 0.00% -0.190 pp | 0.00% -0.133 pp | USD— | 2 qtrs SOLD |
| 85 | EAM INVESTORS, LLC | — -117.6K (-100.0%) | — -1.3M (-100.0%) | 0.00% -0.558 pp | 0.00% -0.148 pp | USD— | 3 qtrs SOLD |
| 86 | QUADRATURE CAPITAL LTD | — -11.4K (-100.0%) | — -124.8K (-100.0%) | 0.00% -0.054 pp | 0.00% -0.002 pp | USD— | 3 qtrs SOLD |
| 87 | ALLWORTH FINANCIAL LP | — -2.0K (-100.0%) | — -22.0K (-100.0%) | 0.00% -0.010 pp | 0.00% 0.000 pp | USD— | 14 qtrs SOLD |
| 88 | EHP FUNDS INC. | — -90.8K (-100.0%) | — -998.0K (-100.0%) | 0.00% -0.431 pp | 0.00% -0.881 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 18 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.45% | 98.0K | 0.20% |
| 2 | iShares Micro-Cap ETF IWC | 0.02% | 249.0K | 0.60% |
| 3 | Vanguard Extended Market ETF VXF | 0.00% | 873.3K | 0.05% |
| 4 | Dimensional - US Small Cap ETF DFAS | 0.00% | 115.9K | 0.26% |
| 5 | Dimensional - US Sustainability Core 1 ETF DFSU | 0.00% | 15.9K | 0.15% |
| 6 | U.S. Micro Cap Portfolio ETF DFMC | 0.00% | 37.8K | 0.43% |
| 7 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 8.5K | 0.14% |
| 8 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 5.4K | 0.03% |
| 9 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.1K | 0.17% |
| 10 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 14.8K | 0.17% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.00
Bullish
Ratio by volume
3.00
Bullish
Buys
6
Sells
3
Shares acquired
379.0K
Shares disposed
28.7K
Cash buys
—
Cash sales
3.00
Net activity
+350,334
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | McKhann Chas | Director | — | — | Restricted Stock Units | 0 | 0.00 | — | 7,500 | D | ↗ |
| 2026-03-12 | Black Jeffrey G. | Officer | A-Award | A | Common Stock | 75,000 | 3.16 | 237.0K | 342,442 | D | ↗ |
| 2026-03-12 | ABALLI JOHN | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 839,834 | D | ↗ |
| 2026-03-03 | ABALLI JOHN | Director / Officer | A-Award | A | Common Stock | 2,535 | 3.08 | 7.8K | 689,834 | D | ↗ |
| 2026-02-27 | Black Jeffrey G. | Officer | A-Award | A | Common Stock | 1,511 | 3.08 | 4.6K | 343,953 | D | ↗ |
| 2026-02-24 | Black Jeffrey G. | Officer | S-Sale | D | Common Stock | 1,584 | 3.61 | 5.7K | 267,442 | D | ↗ |
| 2026-02-24 | ABALLI JOHN | Director / Officer | S-Sale | D | Common Stock | 11,430 | 3.61 | 41.3K | 702,997 | D | ↗ |
| 2025-10-16 | ABALLI JOHN | Director / Officer | S-Sale | D | Common Stock | 31,787 | 11.82 | 375.6K | 714,427 | D | ↗ |
| 2025-09-02 | Black Jeffrey G. | Officer | S-Sale | D | Common Stock | 20,466 | 9.79 | 200.4K | 269,026 | D | ↗ |
| 2025-07-17 | McKhann Chas | Director | — | — | Restricted Stock Units | 0 | 0.00 | — | 7,500 | D | ↗ |
| 2025-06-10 | Stokes Frank | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 7.36 | 66.2K | 9,000 | D | ↗ |
| 2025-06-10 | Nova Tina Susan | Director | A-Award | A | Stock Option(right to buy) | 13,500 | 7.36 | 99.4K | 13,500 | D | ↗ |
| 2025-06-10 | Kim Paul | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 7.36 | 66.2K | 18,000 | D | ↗ |
| 2025-06-10 | KAHN SCOTT D | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 7.36 | 66.2K | 9,000 | D | ↗ |
| 2025-06-10 | Hooker Ana | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 7.36 | 66.2K | 9,000 | D | ↗ |
| 2025-03-25 | NMSIC Co-Investment Fund, L.P. | 10% Owner | S-Sale | D | Common Stock | 350,000 | 3.30 | 1.16M | 1,758,958 | I | ↗ |
| 2025-02-28 | ABALLI JOHN | Director / Officer | A-Award | A | Common Stock | 8,621 | 2.47 | 21.3K | 746,214 | D | ↗ |
| 2025-02-21 | Black Jeffrey G. | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 289,492 | D | ↗ |
| 2025-02-21 | ABALLI JOHN | Director / Officer | A-Award | A | Stock Option(right to buy) | 75,000 | 3.58 | 268.5K | 75,000 | D | ↗ |
| 2024-11-20 | NMSIC Co-Investment Fund, L.P. | 10% Owner | S-Sale | D | Common Stock | 200,000 | 3.30 | 660.0K | 2,108,958 | I | ↗ |
| 2024-11-15 | Black Jeffrey G. | Officer | P-Purchase | A | Common Stock | 22,298 | 2.98 | 66.4K | 274,492 | D | ↗ |
| 2024-11-14 | ABALLI JOHN | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-01 | Black Jeffrey G. | Officer | — | D | Common Stock | 0 | 0.00 | — | 27,194 | — | ↗ |
| 2024-06-10 | Stokes Frank | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 1.99 | 17.9K | 9,000 | — | ↗ |
| 2024-06-10 | Nova Tina Susan | Director | A-Award | A | Stock Option(right to buy) | 13,500 | 1.99 | 26.9K | 13,500 | — | ↗ |
| 2024-06-10 | Kim Paul | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 1.99 | 17.9K | 9,000 | — | ↗ |
| 2024-06-10 | KAHN SCOTT D | Director | A-Award | A | Stock Option(right to buy) | 15,000 | 1.99 | 29.9K | 15,000 | — | ↗ |
| 2024-06-10 | Hooker Ana | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 1.99 | 17.9K | 9,000 | — | ↗ |
| 2024-05-16 | ABALLI JOHN | Director / Officer | P-Purchase | A | Common Stock | 40,401 | 1.92 | 77.6K | 40,401 | — | ↗ |
| 2024-03-04 | Adawi Kamal | Officer | S-Sale | D | Common Stock | 9,297 | 1.91 | 17.7K | 247,236 | — | ↗ |
| 2024-02-29 | ABALLI JOHN | Director / Officer | A-Award | A | Common Stock | 9,804 | 1.91 | 18.7K | 600,788 | — | ↗ |
| 2024-02-20 | Adawi Kamal | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 256,533 | — | ↗ |
| 2024-02-20 | ABALLI JOHN | Director / Officer | A-Award | A | Common Stock | 175,000 | 0.00 | — | 590,984 | — | ↗ |
| 2024-02-06 | Adawi Kamal | Officer | S-Sale | D | Common Stock | 6,738 | 1.95 | 13.1K | 181,533 | — | ↗ |
| 2023-10-17 | ABALLI JOHN | Director / Officer | S-Sale | D | Common Stock | 33,819 | 1.75 | 59.0K | 415,984 | — | ↗ |
| 2023-08-31 | ABALLI JOHN | Director / Officer | A-Award | A | Common Stock | 9,803 | 2.14 | 21.0K | 449,803 | — | ↗ |
| 2023-07-24 | Kim Paul | Director | A-Award | A | Stock Option(right to buy) | 15,000 | 2.59 | 38.8K | 15,000 | — | ↗ |
| 2023-06-15 | TULLIS JAMES L L | 10% Owner | P-Purchase | A | Common Stock | 167 | 3.11 | 519.45 | 1,515,839 | — | ↗ |
| 2023-06-15 | Nova Tina Susan | Director / Officer | A-Award | A | Stock Option(right to buy) | 13,500 | 3.22 | 43.5K | 13,500 | — | ↗ |
| 2023-06-09 | Stokes Frank | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 3.13 | 28.2K | 9,000 | — | ↗ |
| 2023-06-09 | PALLARES EBETUEL | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 3.13 | 28.2K | 9,000 | — | ↗ |
| 2023-06-09 | Johnson Wendy S. | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 3.13 | 28.2K | 9,000 | — | ↗ |
| 2023-06-09 | Hooker Ana | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 3.13 | 28.2K | 9,000 | — | ↗ |
| 2023-06-09 | Birk Brian | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 3.13 | 28.2K | 9,000 | — | ↗ |
| 2023-03-02 | Hazeltine Mark | Officer | S-Sale | D | Common Stock | 3,667 | 0.00 | — | 190,205 | — | ↗ |
| 2023-03-02 | Adawi Kamal | Officer | S-Sale | D | Common Stock | 3,667 | 2.30 | 8.4K | 188,271 | — | ↗ |
| 2023-02-27 | Hazeltine Mark | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 193,872 | — | ↗ |
| 2023-02-27 | Adawi Kamal | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 191,938 | — | ↗ |
| 2023-02-08 | Hazeltine Mark | Officer | S-Sale | D | Common Stock | 5,821 | 2.69 | 15.7K | 93,872 | — | ↗ |
| 2023-02-08 | Adawi Kamal | Officer | S-Sale | D | Common Stock | 5,821 | 2.69 | 15.7K | 91,938 | — | ↗ |
| 2022-12-08 | ABALLI JOHN | Officer | P-Purchase | A | Common Stock | 90,000 | 2.68 | 241.2K | 440,000 | — | ↗ |
| 2022-10-16 | ABALLI JOHN | Officer | A-Award | A | Restricted Stock Units | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2022-06-16 | TULLIS JAMES L L | Director / 10% Owner | A-Award | A | Stock Option(right to buy) | 9,000 | 5.25 | 47.3K | 9,000 | — | ↗ |
| 2022-06-16 | Stokes Frank | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 5.25 | 47.3K | 9,000 | — | ↗ |
| 2022-06-16 | PALLARES EBETUEL | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2022-06-16 | Nova Tina Susan | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2022-06-16 | Johnson Wendy S. | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2022-06-16 | Hooker Ana | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2022-06-16 | Birk Brian | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2022-03-01 | Zack Debra | Officer | F-InKind | D | Common Stock | 3,241 | 7.12 | 23.1K | 84,259 | — | ↗ |
| 2022-03-01 | Rocca Fortunato R. | Officer | F-InKind | D | Common Stock | 4,322 | 7.12 | 30.8K | 120,678 | — | ↗ |
| 2022-03-01 | Hazeltine Mark | Officer | F-InKind | D | Common Stock | 3,241 | 7.12 | 23.1K | 99,693 | — | ↗ |
| 2022-03-01 | Adawi Kamal | Officer | F-InKind | D | Common Stock | 3,241 | 7.12 | 23.1K | 97,759 | — | ↗ |
| 2022-02-04 | Zack Debra | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 87,500 | — | ↗ |
| 2022-02-04 | Rocca Fortunato R. | Director / Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 125,000 | — | ↗ |
| 2022-02-04 | Hazeltine Mark | Officer | A-Award | A | Common Stock | 63,500 | 0.00 | — | 102,934 | — | ↗ |
| 2022-02-04 | Adawi Kamal | Officer | A-Award | A | Common Stock | 63,500 | 0.00 | — | 101,000 | — | ↗ |
| 2021-09-03 | Johnson Wendy S. | Director | P-Purchase | A | Common Stock | 1,000 | 14.02 | 14.0K | 1,000 | — | ↗ |
| 2021-08-05 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 6,800 | 10.72 | 72.9K | 1,515,672 | — | ↗ |
| 2021-08-04 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 2,100 | 11.39 | 23.9K | 1,522,472 | — | ↗ |
| 2021-08-03 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 4,300 | 11.77 | 50.6K | 1,524,572 | — | ↗ |
| 2021-08-02 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 1,800 | 11.92 | 21.5K | 1,528,872 | — | ↗ |
| 2021-07-29 | Hooker Ana | Director | A-Award | A | Stock Option(right to buy) | 15,000 | 12.28 | 184.2K | 15,000 | — | ↗ |
| 2021-06-29 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 5,379 | 14.67 | 78.9K | 1,530,672 | — | ↗ |
| 2021-06-28 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 10,858 | 14.98 | 162.7K | 1,536,051 | — | ↗ |
| 2021-06-25 | TULLIS JAMES L L | Director | S-Sale | D | Common Stock | 8,763 | 16.03 | 140.5K | 1,546,909 | — | ↗ |
| 2021-06-17 | TULLIS JAMES L L | Director / 10% Owner | A-Award | A | Stock Option(right to buy) | 9,000 | 16.41 | 147.7K | 9,000 | — | ↗ |
| 2021-06-17 | Stokes Frank | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Robertson Bruce C | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 16.41 | 147.7K | 9,000 | — | ↗ |
| 2021-06-17 | PALLARES EBETUEL | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 16.41 | 147.7K | 9,000 | — | ↗ |
| 2021-06-17 | Nova Tina Susan | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 16.41 | 147.7K | 9,000 | — | ↗ |
| 2021-06-17 | Johnson Wendy S. | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 16.41 | 147.7K | 9,000 | — | ↗ |
| 2021-06-17 | Birk Brian | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 16.41 | 147.7K | 9,000 | — | ↗ |
| 2021-05-17 | Hazeltine Mark | Officer | M-Exempt | A | Common Stock | 1,934 | 0.26 | 502.84 | 39,434 | — | ↗ |
| 2021-03-13 | Hazeltine Mark | Officer | — | D | Stock Option(right to buy) | 680 | 45.91 | 31.2K | 0 | — | ↗ |
| 2021-02-23 | Zack Debra | Officer | A-Award | A | Common Stock | 37,500 | 0.00 | — | 37,500 | — | ↗ |
| 2021-02-23 | Rocca Fortunato R. | Director / Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2021-02-23 | Adawi Kamal | Officer | A-Award | A | Common Stock | 37,500 | 0.00 | — | 37,500 | — | ↗ |
| 2021-02-05 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 3,000 | 17.00 | 51.0K | 21,348 | — | ↗ |
| 2021-01-25 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 28,021 | 16.01 | 448.6K | 1,261,324 | — | ↗ |
| 2021-01-22 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 23,646 | 16.07 | 380.0K | 1,289,345 | — | ↗ |
| 2021-01-21 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 50,000 | 16.01 | 800.7K | 1,312,991 | — | ↗ |
| 2021-01-20 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 30,000 | 16.13 | 484.0K | 1,362,991 | — | ↗ |
| 2021-01-19 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 257 | 15.56 | 4.0K | 24,348 | — | ↗ |
| 2021-01-19 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 30,000 | 16.00 | 480.0K | 1,392,991 | — | ↗ |
| 2021-01-15 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 1,014 | 15.51 | 15.7K | 24,605 | — | ↗ |
| 2021-01-13 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 4,000 | 15.58 | 62.3K | 25,619 | — | ↗ |
| 2021-01-12 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 15,000 | 16.04 | 240.6K | 1,422,991 | — | ↗ |
| 2021-01-11 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 7,394 | 16.03 | 118.5K | 1,437,991 | — | ↗ |
| 2021-01-08 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 15,186 | 16.07 | 244.0K | 1,445,385 | — | ↗ |
| 2021-01-07 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 10,000 | 16.04 | 160.4K | 1,460,571 | — | ↗ |
| 2020-12-15 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 12,000 | 12.23 | 146.7K | 1,555,672 | — | ↗ |
| 2020-12-15 | NMSIC Co-Investment Fund, L.P. | 10% Owner | S-Sale | D | Common Stock | 125,000 | 12.00 | 1.50M | 2,308,958 | — | ↗ |
| 2020-12-11 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 7,500 | 13.04 | 97.8K | 1,567,672 | — | ↗ |
| 2020-12-10 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 10,000 | 14.03 | 140.3K | 1,575,172 | — | ↗ |
| 2020-11-11 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 150 | 16.00 | 2.4K | 1,470,571 | — | ↗ |
| 2020-11-10 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 9,045 | 16.06 | 145.3K | 1,470,721 | — | ↗ |
| 2020-11-09 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 882 | 16.21 | 14.3K | 31,348 | — | ↗ |
| 2020-11-09 | Hunt Holdings Limited Partnership | 10% Owner | S-Sale | D | Common Stock | 6,752 | 16.04 | 108.3K | 1,479,766 | — | ↗ |
| 2020-10-19 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 198 | 16.02 | 3.2K | 32,127 | — | ↗ |
| 2020-10-16 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 2,104 | 16.25 | 34.2K | 32,325 | — | ↗ |
| 2020-10-15 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 4,316 | 14.88 | 64.2K | 34,429 | — | ↗ |
| 2020-10-01 | Johnson Wendy S. | Director | A-Award | A | Stock Option(right to buy) | 15,000 | 11.25 | 168.8K | 15,000 | — | ↗ |
| 2020-09-11 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 15,000 | 12.40 | 186.0K | 1,585,275 | — | ↗ |
| 2020-09-01 | NMSIC Co-Investment Fund, L.P. | 10% Owner | S-Sale | D | Common Stock | 126,404 | 12.50 | 1.58M | 2,433,958 | — | ↗ |
| 2020-08-18 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 2,082 | 14.52 | 30.2K | 1,600,275 | — | ↗ |
| 2020-08-14 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 11,507 | 16.95 | 195.1K | 1,602,357 | — | ↗ |
| 2020-06-18 | TULLIS JAMES L L | Director / 10% Owner | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-18 | Robertson Bruce C | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-18 | PALLARES EBETUEL | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-18 | Nova Tina Susan | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-18 | Elliott Jeffrey Thomas | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-18 | Burrell Chet | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-18 | Birk Brian | Director | A-Award | A | Stock Option(right to buy) | 9,000 | 13.00 | 117.0K | 9,000 | — | ↗ |
| 2020-06-09 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 1,522 | 12.77 | 19.4K | 1,618,646 | — | ↗ |
| 2020-05-28 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 2,240 | 11.93 | 26.7K | 1,620,168 | — | ↗ |
| 2020-05-27 | TULLIS JAMES L L | Director / 10% Owner | S-Sale | D | Common Stock | 1,595 | 12.57 | 20.1K | 1,622,408 | — | ↗ |
| 2020-05-20 | TULLIS JAMES L L | Director / 10% Owner | J-Other | D | Common Stock | 1,162 | 0.00 | — | 1,624,003 | — | ↗ |
| 2020-04-13 | PALLARES EBETUEL | Director | J-Other | D | Common Stock | 144,033 | 0.00 | — | 0 | — | ↗ |
| 2020-04-13 | Hunt Holdings Limited Partnership | 10% Owner | J-Other | A | Common Stock | 7,703 | 0.00 | — | 1,486,518 | — | ↗ |
| 2020-03-24 | Zack Debra | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-03-20 | TULLIS JAMES L L | Director / 10% Owner | J-Other | D | Common Stock | 164,420 | 0.00 | — | 1,625,165 | — | ↗ |
| 2020-03-20 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. | 10% Owner | J-Other | D | Common Stock | 164,420 | 0.00 | — | 1,625,165 | — | ↗ |
| 2020-03-11 | PALLARES EBETUEL | Director | M-Exempt | D | Warrants | 2,265 | 1.84 | 4.2K | 0 | — | ↗ |
| 2020-01-09 | Rocca Fortunato R. | Director / Officer | A-Award | A | Stock Option(right to buy) | 155,000 | 24.19 | 3.75M | 155,000 | — | ↗ |
| 2020-01-09 | Adawi Kamal | Officer | A-Award | A | Stock Option(right to buy) | 52,500 | 24.19 | 1.27M | 52,500 | — | ↗ |
| 2019-09-23 | TULLIS JAMES L L | Director / 10% Owner | C-Conversion | A | Common Stock | 4,537 | 0.00 | — | 4,537 | — | ↗ |
| 2019-09-23 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. | 10% Owner | C-Conversion | D | Series C Redeemable Convertible Preferred Stock | 5,446,902 | 0.00 | — | 0 | — | ↗ |
| 2019-09-23 | PALLARES EBETUEL | Director | C-Conversion | A | Common Stock | 120,609 | 0.00 | — | 121,667 | — | ↗ |
| 2019-09-23 | NMSIC Co-Investment Fund, L.P. | 10% Owner | C-Conversion | A | Common Stock | 2,228,500 | 0.00 | — | 2,560,362 | — | ↗ |
| 2019-09-23 | Hunt Holdings Limited Partnership | 10% Owner | C-Conversion | D | Series A-3 Redeemable Convertible Preferred Stock | 219,548 | 0.00 | — | 0 | — | ↗ |
| 2019-09-23 | H.I.G. Bio-Exagen, L.P. | 10% Owner | C-Conversion | D | Series H Redeemable Convertible Preferred Stock | 233,446,519 | 0.00 | — | 0 | — | ↗ |
| 2019-09-19 | TULLIS JAMES L L | Director / 10% Owner | F-InKind | D | Common Stock | 8,865 | 18.58 | 164.7K | 2,732 | — | ↗ |
| 2019-09-19 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. | 10% Owner | X-InTheMoney | A | Common Stock | 11,498 | 14.32 | 164.7K | 11,597 | — | ↗ |
| 2019-09-19 | PALLARES EBETUEL | Director | X-InTheMoney | D | Warrants | 3,839 | 14.32 | 55.0K | 0 | — | ↗ |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. | 10% Owner | F-InKind | D | Common Stock | 49,860 | 18.58 | 926.4K | 331,862 | — | ↗ |
| 2019-09-19 | Hunt Holdings Limited Partnership | 10% Owner | X-InTheMoney | D | Warrants | 10,557 | 14.32 | 151.2K | 0 | — | ↗ |
| 2019-09-18 | TULLIS JAMES L L | Director / 10% Owner | — | I | Warrants | 1,361 | 688.63 | 937.2K | 0 | — | ↗ |
| 2019-09-18 | TULLIS DICKERSON CAPITAL FOCUS III, L.P. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 99 | — | ↗ |
| 2019-09-18 | Rocca Fortunato R. | Director / Officer | A-Award | A | Stock Option(right to buy) | 138,659 | 14.00 | 1.94M | 138,659 | — | ↗ |
| 2019-09-18 | Robertson Bruce C | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | PALLARES EBETUEL | Director | — | I | Series F Redeemable Convertible Preferred Stock | 43,405 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | Nova Tina Susan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | NMSIC Co-Investment Fund, L.P. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 12,074 | — | ↗ |
| 2019-09-18 | Hunt Holdings Limited Partnership | 10% Owner | — | I | Series H Redeemable Convertible Preferred Stock | 294,854 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | H.I.G. Bio-Exagen, L.P. | 10% Owner | — | I | Series H Redeemable Convertible Preferred Stock | 1,271,252 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | Elliott Jeffrey Thomas | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | Dervieux Thierry | Officer | — | D | Stock Option (Right to Buy) | 97,110 | 0.26 | 25.0K | 0 | — | ↗ |
| 2019-09-18 | Burrell Chet | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | Birk Brian | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-09-18 | Adawi Kamal | Officer | — | D | Stock Option (Right to Buy) | 84,162 | 0.26 | 21.6K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-67.3K
Shares Outstanding
24.05M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | John Aballi President, Chief Executive Officer, Director and former Interim Chief Financial Officer | 540.0K | — | 402.8K | 203.0K | 237.6K | 17.5K | 1.40M | 43.24% | ↗ |
| 2 | 2025 | Jeffrey Black Chief Financial Officer and Corporate Secretary | 465.0K | — | 53.7K | 27.1K | 186.0K | 14.4K | 746.2K | 10.82% | ↗ |
| 3 | 2024 | John Aballi President, Chief Executive Officer, and Director | 525.0K | — | 353.5K | — | 288.8K | 17.3K | 1.18M | 29.84% | ↗ |
| 4 | 2024 | John Aballi President, Chief Executive Officer, Director and former Interim Chief Financial Officer | 525.0K | — | 353.5K | — | 288.8K | 17.3K | 1.18M | 29.84% | ↗ |
| 5 | 2024 | Jeffrey Black Chief Financial Officer and Corporate Secretary | 141.5K | 125.0K | 670.5K | — | 84.0K | — | 1.02M | 65.67% | ↗ |
| 6 | 2024 | Kamal Adawi Former Chief Financial Officer and Corporate Secretary | 253.7K | — | 151.5K | — | — | 385.1K | 790.3K | 19.17% | ↗ |
| 7 | 2023 | Mark Hazeltine former Chief Business Officer | 378.4K | — | 239.0K | — | — | 436.6K | 1.05M | 22.68% | ↗ |
| 8 | 2023 | John Aballi President and Chief Executive Officer | 525.0K | 76.1K | — | — | 317.6K | 13.2K | 932.0K | 0.00% | ↗ |
| 9 | 2023 | John Aballi President, Chief Executive Officer, and Director | 525.0K | 76.1K | — | — | 317.6K | 13.2K | 932.0K | 0.00% | ↗ |
| 10 | 2023 | Kamal Adawi Former Chief Financial Officer and Corporate Secretary | 406.5K | 35.1K | 239.0K | — | 221.3K | 13.2K | 915.1K | 26.12% | ↗ |
| 11 | 2023 | Kamal Adawi Chief Financial Officer and Corporate Secretary | 406.5K | 35.1K | 239.0K | — | 221.3K | 13.2K | 915.1K | 26.12% | ↗ |
| 12 | 2022 | Fortunato Ron Rocca former President and Chief Executive Officer | 447.2K | — | 657.8K | — | — | 437.1K | 1.54M | 42.65% | ↗ |
| 13 | 2022 | Mark Hazeltine Chief Business Officer | 398.5K | 72.6K | 556.9K | — | — | 12.2K | 1.04M | 53.54% | ↗ |
| 14 | 2022 | Kamal Adawi Chief Financial Officer and Corporate Secretary | 398.5K | 72.6K | 556.9K | — | — | 12.2K | 1.04M | 53.54% | ↗ |
| 15 | 2022 | Mark Hazeltine former Chief Business Officer | 398.5K | 72.6K | 556.9K | — | — | 12.2K | 1.04M | 53.54% | ↗ |
| 16 | 2022 | Debra Zack, M.D., Ph.D. former Chief Medical Officer | 373.7K | — | 438.5K | — | — | 213.8K | 1.03M | 42.74% | ↗ |
| 17 | 2022 | John Aballi President and Chief Executive Officer | 111.1K | 22.3K | 850.5K | — | — | — | 983.9K | 86.44% | ↗ |
| 18 | 2021 | Fortunato Ron Rocca President and Chief Executive Officer | 594.7K | — | 910.0K | 388.6K | 537.6K | 8.7K | 2.44M | 53.23% | ↗ |
| 19 | 2021 | Fortunato Ron Rocca former President and Chief Executive Officer | 594.7K | — | 910.0K | 388.6K | 537.6K | 8.7K | 2.44M | 53.23% | ↗ |
| 20 | 2021 | Debra Zack, M.D., Ph.D. Chief Medical Officer | 415.5K | — | 682.5K | 121.4K | 202.6K | 8.6K | 1.43M | 56.20% | ↗ |
| 21 | 2021 | Debra Zack, M.D., Ph.D. former Chief Medical Officer | 415.5K | — | 682.5K | 121.4K | 202.6K | 8.6K | 1.43M | 56.20% | ↗ |
| 22 | 2021 | Kamal Adawi Chief Financial Officer and Corporate Secretary | 406.4K | — | 682.5K | 121.4K | 194.6K | 8.7K | 1.41M | 56.87% | ↗ |
| 23 | 2021 | Mark Hazeltine Chief Business Officer | 390.6K | — | 682.5K | 121.4K | 194.6K | 8.7K | 1.40M | 57.52% | ↗ |
| 24 | 2020 | Fortunato Ron Rocca President and Chief Executive Officer | 499.7K | — | — | 1.74M | 566.8K | 8.6K | 2.82M | 61.85% | ↗ |
| 25 | 2020 | Kamal Adawi Chief Financial Officer and Corporate Secretary | 381.2K | — | — | 590.2K | 230.6K | 8.6K | 1.21M | 48.76% | ↗ |
| 26 | 2020 | Debra Zack, M.D., Ph.D. Chief Medical Officer | 296.7K | — | — | 633.4K | 185.6K | 6.5K | 1.12M | 56.44% | ↗ |
| 27 | 2019 | Fortunato Ron Rocca President and Chief Executive Officer | 358.2K | 73.9K | — | 1.08M | 105.2K | 8.4K | 1.63M | 66.48% | ↗ |
| 28 | 2019 | Kamal Adawi Chief Financial Officer and Corporate Secretary | 278.1K | 28.7K | — | 168.8K | 40.8K | 8.4K | 524.9K | 32.17% | ↗ |
| 29 | 2019 | Thierry Dervieux, Ph.D. Chief Scientific Officer | 268.8K | 27.7K | — | 85.0K | 39.4K | 46.1K | 467.0K | 18.20% | ↗ |
| 30 | 2018 | Fortunato Ron Rocca President and Chief Executive Officer | 348.1K | 157.4K | — | 53.5K | — | 8.3K | 567.2K | 9.43% | ↗ |
| 31 | 2018 | Thierry Dervieux, Ph.D. Chief Scientific Officer | 278.4K | 62.9K | — | 16.1K | — | 8.3K | 365.6K | 4.39% | ↗ |
| 32 | 2018 | Kamal Adawi Chief Financial Officer and Corporate Secretary | 271.0K | 61.1K | — | 13.9K | — | 8.3K | 354.3K | 3.93% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John Aballi | Chief Executive Officer, President & Director | 795.1K | male |
| Jeffrey G. Black | Chief Financial Officer & Corporate Secretary | 665.4K | male |
| Prashanti Reddy | Chief Medical Officer | 626.6K | — |
| Tina S. Nova | Executive Chairman of the Board of Directors | 125.0K | — |
| Michael Mahler | Chief Scientific Officer | — | — |
| Ryan Douglas | Investors Relations Officer | — | male |
| Tina Jacobsen | Vice President of Investor Relations | — | female |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for XGN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
